ad26.zebov

Trade name: Zabdeno

Vaccineexperimental

Clinical trial activity

25 trials · 31 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
18
Phase 3
8
Phase 4
0

Earliest trial started Dec 17, 2014 (NCT02313077)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2015

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • EbolavirusImmunity, active

    Ebolavirus immunity, active

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ad26.zebov

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06126822Phase 3Mar 31, 2024Institute of Tropical Medicine, Belgium
NCT05284097Phase 2Sep 19, 2022Janssen Pharmaceutica NV, University of London, University of Sierra Leone
NCT05064956Phase 2Oct 6, 2021Medical Research Council-UVRI Uganda Research Unit on AIDS, University of London, University of Nairobi
NCT04711356Phase 2Jul 8, 2021European Commission, University of London, University of Sierra Leone
NCT04556526Phase 3Oct 5, 2020Center for Family Health Research (CFHR), Coalition for Epidemic Preparedness Innovations, Emory University, Janssen Pharmaceutica NV
NCT04228783Phase 3Feb 18, 2020Janssen Pharmaceutica NV
NCT04186000Phase 2Dec 16, 2019ace africa, Coalition for Epidemic Preparedness Innovations, European Commission, Johnson and Johnson, University of Antwerp, University of Kinshasa
NCT04152486Phase 3Nov 14, 2019Coalition for Epidemic Preparedness Innovations, Epicentre, Government of the Democratic Republic of the Congo, Janssen Pharmaceutica NV, Medecins Sans Frontieres, Public Health England, University of London
NCT04028349Phase 2Jul 31, 2019Coalition for Epidemic Preparedness Innovations, Epicentre, Paris, France and Mbarara, Uganda, Janssen Pharmaceutica NV, Medical Research Council-UVRI Uganda Research Unit on AIDS
NCT03929757Phase 2Jul 12, 2019Janssen Pharmaceutica NV
NCT02876328Phase 2Mar 31, 2017Institut National de la Santé Et de la Recherche Médicale, France, National Institute of Allergy and Infectious Diseases (NIAID), Redemption Hospital, The Liberia-US Clinical Trials Partnership Program, Partnership for Research on Ebola Virus in Liberia Project, University of London, University of Sierra Leone
NCT02891980Phase 1Sep 1, 2016National Institute of Allergy and Infectious Diseases (NIAID)
NCT02860650Phase 1Aug 29, 2016Janssen Pharmaceutica NV, Johnson and Johnson, National Institute of Allergy and Infectious Diseases (NIAID)
NCT02661464Phase 3May 31, 2016Bavarian Nordic, Janssen Pharmaceutica NV, Johnson and Johnson
NCT02598388Phase 2Dec 10, 2015Janssen Pharmaceutica NV, Johnson and Johnson, United States Army
NCT02564523Phase 2Nov 6, 2015EBOVAC2 Consortium, Janssen Pharmaceutica NV, Johnson and Johnson
NCT02509494Phase 3Sep 30, 2015Government of Sierra Leone, Grameen Foundation, Institut National de la Santé Et de la Recherche Médicale, France, Janssen Pharmaceutica NV, Johnson and Johnson, University of London, University of Oxford, University of Sierra Leone, World Vision of Ireland
NCT02495246Phase 1Sep 21, 2015University of Oxford
NCT02543567Phase 3Sep 21, 2015Janssen Pharmaceutica NV, Johnson and Johnson
NCT02543268Phase 3Sep 1, 2015Crucell
Showing 20 of 25 trials
Page 1 / 2

Organizations

Research & Development (31)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Janssen Pharmaceutica NVFor profit14332015
Johnson and JohnsonFor profit9832015
University of LondonAcademic/Hospital6422015
Coalition for Epidemic Preparedness InnovationsAcademic/Hospital4022019
CrucellFor profit4422014
University of Sierra LeoneAcademic/Hospital4022015
Institut National de la Santé Et de la Recherche Médicale, FranceAcademic/Hospital3022015
National Institute of Allergy and Infectious Diseases (NIAID)Government3222016
European CommissionGovernment2012019
Medical Research Council-UVRI Uganda Research Unit on AIDSAcademic/Hospital2112019
University of OxfordAcademic/Hospital2122015
ace africaAcademic/Hospital1012019
Bavarian NordicFor profit1012016
Center for Family Health Research (CFHR)Academic/Hospital1012020
EBOVAC2 ConsortiumAcademic/Hospital1012015
Emory UniversityAcademic/Hospital1012020
EpicentreFor profit1012019
Epicentre, Paris, France and Mbarara, UgandaAcademic/Hospital1012019
Government of Sierra LeoneGovernment1012015
Government of the Democratic Republic of the CongoGovernment1012019
31 organizations
Page 1 / 2